产品名称
柠檬酸钙四水合物, 99%
InChI key
LNIZKKFWMDARJV-UHFFFAOYSA-H
InChI
1S/2C6H8O7.3Ca.4H2O/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;4*1H2/q;;3*+2;;;;/p-6
SMILES string
[H]O[H].[H]O[H].[H]O[H].[H]O[H].OC1(CC(=O)O[Ca]OC(=O)C1)C(=O)O[Ca]OC(=O)C2(O)CC(=O)O[Ca]OC(=O)C2
assay
99%
form
powder
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
柠檬酸钙四水合物可以作为原材料,通过溶胶-凝胶法制备纳米颗粒,其标称成分为 Ca0.8 Ba0.2 Ti03:Pr3+。它可以作为碳源,以一种简单有效的碳化方法制备多孔碳,无需任何活化步骤。它适用于制备牛血清白蛋白(BSA)纳米颗粒。
General description
通过 TG、DTA 和 DSC 研究了柠檬酸钙四水合物在动态空气或干燥氮气中的热分解。
存储类别
11 - Combustible Solids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
An activation-free protocol for preparing porous carbon from calcium citrate and the capacitive performance.
Zhou QQ, et al.
Microporous and Mesoporous Materials : The Official Journal of the International Zeolite Association, 158, 155-161 (2012)
Preparation of size-controlled bovine serum albumin (BSA) nanoparticles by a modified desolvation method.
Jun JY, et al.
Food Chemistry, 127(4), 1892-1898 (2011)
Yannan Mu et al.
Luminescence : the journal of biological and chemical luminescence, 30(5), 503-506 (2014-09-12)
Nanoparticles with the nominal composition Ca0.8Ba0.2Ti03:Pr(3+) were prepared using the sol-gel process. Barium nitrate, 4-hydrated calcium nitrate and praseodymium oxide were used as raw materials. The structural evolution and decomposition processes of the precursors were investigated by powder X-ray diffraction
Thermal decomposition of calcium citrate tetrahydrate.
Mansour SAA.
Thermochimica Acta, 233(2), 243-256 (1994)
Jochen Klaus et al.
World journal of gastroenterology, 17(3), 334-342 (2011-01-22)
To compare the effect of calcium and cholecalciferol alone and along with additional sodium fluoride or ibandronate on bone mineral density (BMD) and fractures in patients with Crohn's disease (CD). Patients (n =148) with reduced BMD (T-score < -1) were
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持